HAP Trading’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-25,400
Closed -$69K 1132
2017
Q2
$69K Sell
25,400
-26,800
-51% -$797K ﹤0.01% 648
2017
Q1
$11K Buy
+52,200
New +$1.31M ﹤0.01% 908

Other funds holding GBT

HAP Trading's GBT Position: Q2 2018 in Review

HAP Trading sold out of Global Blood Therapeutics, Inc. (GBT) in Q2 2018, closing a stake of 27,698 shares — an estimated $1.26M sold.

HAP Trading first reported a position in GBT in Q4 2017 and held it in 2 quarters. The position peaked at $1.34M in Q1 2018. 196 funds tracked by Wall St. Rank hold GBT as of Q2 2018.

  • HAP Trading reported no remaining Global Blood Therapeutics, Inc. position as of Q2 2018 after selling out during the quarter.
  • HAP Trading sold 27,698 Global Blood Therapeutics, Inc. shares in Q2 2018, an estimated $1.26M.
  • HAP Trading first reported a position in Global Blood Therapeutics, Inc. in Q4 2017 and held it in 2 quarters.
  • HAP Trading's Global Blood Therapeutics, Inc. position peaked at $1.34M in Q1 2018.
  • 196 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q2 2018.

Based on HAP Trading's 13F filing for Q2 2018, filed 13 Aug 2018.